Selenium effect on oxidative stress factors in septic rats

Advanced Pharmaceutical Bulletin

Volumn 4, Issue 3, 2014, Pages 289-293

  Zolali, Elmira ^a,b   Hamishehkar, Hadi ^a,c   Maleki Dizaji, Nasrin ^a   Zolbanin, Naime Majidi ^a   Ghavimi, Hamed ^c   Kouhsoltani, Maryam ^a   Asgharian, Parina ^a  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

CLP; Oxidative stress; Selenium; Sepsis

Indexed keywords

GLUTATHIONE PEROXIDASE; MALONALDEHYDE; MYELOPEROXIDASE; REACTIVE OXYGEN METABOLITE; SELENIUM; SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; HISTOPATHOLOGY; MALE; NONHUMAN; OXIDATIVE STRESS; PNEUMONIA; RAT; SEPSIS;

EID: 84983573861     PISSN: 22285881     EISSN: 22517308     Source Type: Journal    
DOI: 10.5681/apb.2014.042     Document Type: Article

References (19)

1. Kumar V, Sharma A. Is neuroimmunomodulation a future therapeutic approach for sepsis? Int Immunopharmacol 2010;10(1):9-17.
2. Bernard GR, Vincent JL, Laterre PF, Larosa SP, Dhainaut JF, Lopez-Rodriguez A, et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001;344(10):699-709.
3. Macdonald J, Galley HF, Webster NR. Oxidative stress and gene expression in sepsis. Br J Anaesth 2003;90(2):221-32.
4. Carlos WG, Curtis Ramsey M, Fraiz J. Selenium in Early Sepsis: A Marker for Change? Advances in Sepsis 2008;6(3):99-102.
5. Strachan S, Wyncoll D. Selenium in critically ill patients. J Intensive Care Soc 2009;10:38-43.
6. Heyland DK. Selenium supplementation in critically ill patients: can too much of a good thing be a bad thing. Crit Care 2007;11(4):153.
7. Rittirsch D, Huber-Lang MS, Flierl MA, Ward PA. Immunodesign of experimental sepsis by cecal ligation and puncture. Nat Protoc 2008;4(1):31-6.
8. Bradley PP, Priebat DA, Christensen RD, Rothstein G. Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J Invest Dermatol 1982;78(3):206-9.
9. Olgen S, Coban T. Antioxidant evaluations of novel N-H and N-substituted indole esters. Biol Pharm Bull 2003;26(5):736-8.
10. Paoletti F, Aldinucci D, Mocali A, Caparrini A. A sensitive spectrophotometric method for the determination of superoxide dismutase activity in tissue extracts. Anal Biochem 1986;154(2):536-41.
11. Paglia DE, Valentine WN. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 1967;70(1):158-69.
12. Atli M, Erikoglu M, Kaynak A, Esen HH, Kurban S. The effects of selenium and vitamin E on lung tissue in rats with sepsis. Clin Invest Med 2012;35(2):E48-54.
13. Lykkesfeldt J, Svendsen O. Oxidants and antioxidants in disease: oxidative stress in farm animals. Vet J 2007;173(3):502-11.
14. Xu HB, Mei WD, Dong ZM, Liao BL. Study of the oxidative metabolic function and chemotaxis of neutrophils from patients with cancer influenced by selenium yeast. Biol Trace Elem Res 1990;25(3):201-9.
15. Ozturk E, Demirbilek S, Begec Z, Surucu M, Fadillioglu E, Ki{dotless}ri{dotless}mli{dotless}oglu H, et al. Does leflunomide attenuate the sepsis-induced acute lung injury? Pediatr Surg Int 2008;24(8):899-905.
16. Andrades M, Ritter C, Moreira JC, Dal-Pizzol F. Oxidative parameters differences during non-lethal and lethal sepsis development. J Surg Res 2005;125(1):68-72.
17. Warner BW, Hasselgren PO, James JH, Bialkowska H, Rigel DF, Ogle C, et al. Superoxide dismutase in rats with sepsis. Effect on survival rate and amino acid transport. Arch Surg 1987;122(10):1142-6.
18. Toklu HZ, Tunali Akbay T, Velioglu-Ogunc A, Ercan F, Gedik N, Keyer-Uysal M, et al. Silymarin, the antioxidant component of Silybum marianum, prevents sepsis-induced acute lung and brain injury. J Surg Res 2008;145(2):214-22.
19. Koksal G, Sayilgan C, Aydin S, Oz H, Uzun H. Correlation of plasma and tissue oxidative stresses in intra-abdominal sepsis. J Surg Res 2004;122(2):180-3.